Search

Your search keyword '"Kluk, Michael J."' showing total 178 results

Search Constraints

Start Over You searched for: Author "Kluk, Michael J." Remove constraint Author: "Kluk, Michael J."
178 results on '"Kluk, Michael J."'

Search Results

3. A case of testicular diffuse large B-cell lymphoma with late relapse in the skin: the critical role of comparative phenotypic, clonality, and cytogenetic testing.

4. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas

7. Spatial Mapping of Human Hematopoiesis at Single Cell Resolution Reveals Aging-Associated Topographic Remodeling

8. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas

14. SINGLE CELL RESOLUTION SPATIAL MAPPING OF HUMAN HEMATOPOIESIS REVEALS AGING-ASSOCIATED TOPOGRAPHIC REMODELING

15. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates

27. TCR-dependent transformation of mature memory phenotype T cells in mice

28. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

30. Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML

31. Lysophospholipids--receptor revelations. (Viewpoint)

37. Clinical Laboratory Validation and Implementation of Quantitative, Real-Time PCR-based Detection of NPM1 Type A Mutation.

39. Endothelial sphingosine-1-phosphate receptor 1 deficiency exacerbates brain injury and blood brain barrier dysfunction upon subarachnoid hemorrhage in mice

40. Notch-Regulated Enhancers in B-Cell Lymphoma Activate MYC and Potentiate B-Cell Receptor Signaling

42. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma

43. Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay

45. Cyclin C is a haploinsufficient tumour suppressor

46. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia

49. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry

50. Abstract B39: MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma

Catalog

Books, media, physical & digital resources